Arzeda Debuts Enzyme to Unlock the Potential of Stevia Sweeteners

Arzeda, a protein design company, has successfully developed and scaled its ProSweet Enzymes that will allow sweetener companies to efficiently – and cost effectively – make Reb D and Reb M from stevia leaf extract.

The development and scale of these high-performance enzymes broadens the company’s portfolio of enzymatic stevia solutions – and builds on Arzeda’s work in 2022 and 2023 to efficiently scale and validate enzyme performance for the commercial extraction of Reb D and Reb M glycosides.

Arzeda’s expanded portfolio of Reb D and Reb M ProSweet Enzymes comes on the heels of the company’s development agreement with AAK, further expanding Arzeda’s footprint within the food industry. The introduction of the new enzymes also comes at a time of increased industry demand and product innovation – as global stevia sales are expected to grow by nearly 10% over the next six years due to continued consumer demand for better-for-you alternatives to sugar.

“These breakthrough enzymes are poised to disrupt the food industry, as they offer an effective alternative to extracting once costly Reb D and M glycosides,” said Alexandre Zanghellini, Ph.D., CEO of Arzeda. “We’re excited to bring this solution to our existing partners – and the food industry as a whole – and are confident in the rapid adoption we’ll achieve.”